Morgan Stanley analyst Kallum Titchmarsh lowered the price target on Inspire Medical Systems (NYSE: INSP) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Piper Sandler Reiterates Overweight on Inspire Medical Systems (INSP) as 'P&L Leverage Shines Again'February 11, 2025 6:52 AM Inspire Medical Systems (INSP) PT Raised to $194 at Leerink PartnersFebruary 11, 2025 6:32 AM Inspire Medical Systems (INSP) PT Lowered to $195 at Wells FargoFebruary 11, 2025 6:28 AM Form 10-K Inspire Medical Systems, For: Dec 31February 10, 2025 4:24 PM Inspire Medical Systems (INSP) Tops Q4 EPS by 43c, provides guidanceFebruary 10, 2025 4:10 PM Form 8-K Inspire Medical Systems, For: Feb 10February 10, 2025 4:06 PM Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 OutlookFebruary 10, 2025 4:02 PM Inspire Medical Systems (INSP) PT Lowered to $233 at Piper Sandler Following KOL ChecksFebruary 10, 2025 9:21 AM